Novel diagnosis of systemic lupus erythematosus after first dose of COVID-19 vaccination
Annals of Rheumatology and Autoimmunity · 2022
DOI: 10.4103/ara.ara_10_21 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Rheumatology and Autoimmunity, 2022. Verfasst von Jorge Sanchez-Guerrero und 1 weiteren Autor:innen.
Abstract (Originalsprache)
In the literature, there are two case reports of new diagnoses of systemic lupus erythematosus including a patient with early-onset of class V nephritis; both cases had received the AstraZeneca Vaccine. There are also several cases-reports of autoimmune disease flares after receiving the first or the second dose of the different COVID-19 vaccinations. The severity of the disease flares, the number of doses after which the disease flared, and the approach to control the flare manifestations vary across the reports. The majority of the case reports focus on disease activation rather than a newly diagnosed autoimmune disease after receiving the COVID-19 vaccines. Here, we report a young female with new-onset systemic lupus erythematosus manifesting with arthritis, cutaneous manifestations, and fever 5 days after the first dose of (ChAdOx1 nCoV-19) vaccine.
Zitieren
APA
Sanchez-Guerrero, J., & Alshahrani, K. (2022). Novel diagnosis of systemic lupus erythematosus after first dose of COVID-19 vaccination. Annals of Rheumatology and Autoimmunity. https://doi.org/10.4103/ara.ara_10_21
Vancouver
Sanchez-Guerrero J, Alshahrani K. Novel diagnosis of systemic lupus erythematosus after first dose of COVID-19 vaccination. Annals of Rheumatology and Autoimmunity. 2022. doi:10.4103/ara.ara_10_21
BibTeX
@article{SanchezGuerrero2022,
author = {Sanchez-Guerrero, Jorge and Alshahrani, KhalidS},
title = {Novel diagnosis of systemic lupus erythematosus after first dose of COVID-19 vaccination},
journal = {Annals of Rheumatology and Autoimmunity},
year = {2022},
doi = {10.4103/ara.ara_10_21}
}
EUVIMED